Cancer treatment—systemic therapy agent or protocol, eviQ protocol identifier NNNNNN
Data Element Attributes
Identifying and definitional attributes | |
Metadata item type: | Data Element |
---|---|
Short name: | Systemic therapy agent or protocol, eviQ |
METEOR identifier: | 444090 |
Registration status: | Health!, Superseded 08/05/2014 |
Definition: | The eviQ protocol identifier for the systemic therapy agent protocol administered during the initial course of treatment for cancer. |
Data Element Concept: | Cancer treatment—systemic therapy agent or protocol |
Value Domain: | eviQ protocol identifier NNNNNN |
Value domain attributes | ||
Representational attributes | ||
Representation class: | Identifier | |
---|---|---|
Data type: | String | |
Format: | NNNNNN | |
Maximum character length: | 6 |
Data element attributes | |
Collection and usage attributes | |
Guide for use: | eviQ Cancer Treatments Online is a point of care clinical information resource that provides health professionals with current evidence based, peer maintained, best practice cancer treatment protocols and information. It was developed and is maintained by the Cancer Institute NSW. Record the six digit eviQ protocol identifier (where available) for each systemic therapy agent protocol administered to the patient during the initial treatment of the cancer. The initial course of treatment includes all treatments administered to the patient from diagnosis and before disease progression or recurrence. Systemic therapy agents are drugs that travel through the bloodstream and reach and effect cells all over the body. They are administered orally or intravenously. Systemic therapy may involve a single agent or a combination regimen of two or more drugs. They are administered in treatment cycles. A protocol is a precise and detailed plan for therapy that includes the type, quantity, method and length of time of taking the drugs required for any treatment cycle. The systemic therapy agent eviQ protocol identifier applies to chemotherapy, hormone therapy and immunotherapy administered for the treatment of cancer.
|
---|---|
Collection methods: | This name of the protocol should be obtained from the patient's medical record. |
Comments: | The collection of specific treatment information is useful to evaluate patterns of care, the effectiveness of different treatment modalities, and treatment by patient outcome. |
Source and reference attributes | |
Submitting organisation: | Cancer Australia. |
Origin: | Cancer Institute NSW, eviQ Cancer Treatments Online. |
Reference documents: | Standard Cancer Treatment and Management Pathways Program, Cancer Services and Education Division. eviQ Cancer Treatments Online. Cancer Institute NSW. |
Relational attributes | |
Related metadata references: | Has been superseded by Cancer treatment—systemic therapy agent or protocol, eviQ protocol identifier NNNNNN Health!, Standard 08/05/2014 See also Cancer treatment—systemic therapy agent or protocol, text X[X(149)] Health!, Superseded 08/05/2014 |
Implementation in Data Set Specifications: | Chemotherapy for cancer cluster Health!, Superseded 08/05/2014 Conditional obligation: Conditional on the administration of systemic therapy agents according to a prespecified regimen or protocol, and on the availability of the protocol number on the eviQ website. Hormone therapy for cancer cluster Health!, Superseded 08/05/2014 Conditional obligation: Conditional on the administration of systemic therapy agents according to a prespecified regimen or protocol, and on the availability of the protocol number on the eviQ website. Immunotherapy for cancer cluster Health!, Superseded 08/05/2014 Conditional obligation: Conditional on the administration of systemic therapy agents according to a prespecified regimen or protocol, and on the availability of the protocol number on the eviQ website. |